--- title: "TONGRENTANGCARE temporarily recorded nearly 1.3 billion in margin financing, LAIFUAL's \"head hammer\" only hit one target" type: "News" locale: "en" url: "https://longbridge.com/en/news/291018946.md" description: "Tongrentangcare (2667) has restarted its IPO, temporarily receiving HKD 1.298 billion in oversubscription, approximately 18 times. Its offering price has been adjusted to HKD 5.48-6.21, with the fundraising amount reduced to over HKD 670 million, introducing nearly HKD 300 million in cornerstone investments. During the same period, the allocation results for new stocks such as Laifual and XUNLONG SCITECH have been released, with varying levels of difficulty in winning the lottery. Yikong Zhijia has initiated a pre-roadshow for its Hong Kong listing, expecting to raise approximately USD 300 million" datetime: "2026-06-27T01:34:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291018946.md) - [en](https://longbridge.com/en/news/291018946.md) - [zh-HK](https://longbridge.com/zh-HK/news/291018946.md) --- # TONGRENTANGCARE temporarily recorded nearly 1.3 billion in margin financing, LAIFUAL's "head hammer" only hit one target This year in March, due to various factors including market conditions, TONGRENTANGCARE (2667) halted its listing but is making a comeback, starting its public offering yesterday with a margin of HKD 1.298 billion. With HKD 67.16 million raised from the Hong Kong offering, it was oversubscribed by about 18 times. As for the four new stocks expected to list by the end of the month, the allocation results have been released, with LAIFUAL (3952) being the hardest to get, priced at the highest offering price of HKD 85.5, requiring a "top hammer" to secure one lot. For XUNLONG SCITECH (6715), one must apply for the last 7,000 lots in Group B to secure one lot, with a "top hammer" yielding 1 to 2 lots. ## Easy Control Intelligent Driving Begins Pre-Listing Roadshow Zhenjiankang Medical (2697) and Jiangxi Biological (6915) have secured lots by applying for Group A. Zhenjiankang Medical is priced below the median offering price of HKD 126.2, with a chance of securing 1 lot by applying for 2,000 lots, and a "top hammer" yielding 2 to 3 lots. Jiangxi Biological is priced close to the median offering price of HKD 11.2, with a chance of securing 2 lots by applying for 800 lots, and a "top hammer" yielding 3 to 4 lots. Additionally, IFR reports that Easy Control Intelligent Driving has begun its pre-listing roadshow in Hong Kong, aiming to raise approximately USD 300 million. ## TONGRENTANGCARE's Fundraising Amount Reduced to Over 670 Million TONGRENTANGCARE, which provides traditional Chinese medical services under TONGRENTANG, has the same number of shares issued this time as last time, at nearly 110 million shares, with 10% for the Hong Kong offering and no mandatory clawback, with CICC still as the sponsor. However, the offering price has been adjusted from between HKD 7.3 and 8.3 to between HKD 5.48 and 6.21, thus reducing the fundraising amount from nearly HKD 900 million to over HKD 670 million. Furthermore, the stock has introduced three cornerstone investors from China, with a total subscription amount of nearly HKD 300 million, accounting for 44.1% of this issuance. Among them, two companies are cornerstone investors from its initial public offering in March, with Airport Technology Capital continuing to strongly support, maintaining an investment of HKD 219 million; Aurora SF has reduced its investment from HKD 170 million to HKD 49.6 million ### Related Stocks - [06715.HK](https://longbridge.com/en/quote/06715.HK.md) - [02667.HK](https://longbridge.com/en/quote/02667.HK.md) - [03952.HK](https://longbridge.com/en/quote/03952.HK.md) - [02697.HK](https://longbridge.com/en/quote/02697.HK.md) - [06915.HK](https://longbridge.com/en/quote/06915.HK.md) - [600085.CN](https://longbridge.com/en/quote/600085.CN.md) - [03908.HK](https://longbridge.com/en/quote/03908.HK.md) - [601995.CN](https://longbridge.com/en/quote/601995.CN.md) - [01666.HK](https://longbridge.com/en/quote/01666.HK.md) ## Related News & Research - [Hong Kong's 'Hard Tech' Boom Is a Chaotic Mix of Real AI Hardware and Desperate Corporate Pivots](https://longbridge.com/en/news/290939355.md) - [Jiangxi Rimag says trustee buys 7,501,000 shares on-market for share award scheme](https://longbridge.com/en/news/290552766.md) - [ZAWYA: Abu Dhabi Biobank and BioTwin announce strategic partnership to expand human virtual twin technology in the UAE](https://longbridge.com/en/news/290948225.md) - [ZAWYA: Mubadala Bio partners with Biosidus to advance access to biologic therapies](https://longbridge.com/en/news/290931629.md) - [Micropep files Promisin biofungicide regulatory dossiers in Brazil, Paraguay](https://longbridge.com/en/news/290687977.md)